Food and Drug Administration
Anti-Viral Drugs Advisory Committee
March 19, 2002
NDA 21-245 Picovirô (pleconaril) for treatment of acute picornaviral upper respiratory infection (common cold) in adults
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Sponsor - ViroPharma Incorporated pdf
Food and Drug Administration pdf htm doc